Degarelix
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 359 publications
Resting state functional connectivity in pedophilic disorder and degarelix treatment.
Journal: Acta neuropsychiatrica
Published: April 01, 2026
Effects of a GnRH antagonist on antral follicular development and ovarian hemodynamics in cycling ewes.
Journal: The Journal of reproduction and development
Published: February 15, 2026
Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer.
Journal: Journal for immunotherapy of cancer
Published: February 13, 2026
Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Disproportionality analysis of adverse events associated with degarelix: a real-world study from the FDA Adverse Event Reporting System (FAERS) database.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 29, 2025
Clonal selection of pre-existing neuroendocrine component in prostate cancer during androgen receptor signaling inhibitor therapy: A case report.
Journal: Urology case reports
Published: December 15, 2025
Tumor Lysis Syndrome Induced by Hormonal Therapy in Metastatic Prostate Cancer: A Case Report.
Journal: Cureus
Published: December 07, 2025
Effectiveness and safety of degarelix compared to GnRH agonists for prostate cancer: a systematic review and meta-analysis.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: November 11, 2025
Sex-dependent endocrine and cellular effects of the GnRH antagonist degarelix in rabbits and cell models.
Journal: American journal of translational research
Published: October 31, 2025
Last Updated: 04/28/2026